First Eagle Investment Management LLC reduced its position in shares of Cardinal Health, Inc. (NYSE:CAH – Free Report) by 48.3% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 6,096 shares of the company’s stock after selling 5,704 shares during the quarter. First Eagle Investment Management LLC’s holdings in Cardinal Health were worth $1,356,000 at the end of the most recent reporting period.
Other large investors have also recently added to or reduced their stakes in the company. Bank of New York Mellon Corp purchased a new position in Cardinal Health in the 2nd quarter worth approximately $308,640,000. First Nebraska Trust Co purchased a new stake in Cardinal Health in the 2nd quarter worth approximately $20,050,000. Castlekeep Investment Advisors LLC purchased a new stake in Cardinal Health in the second quarter worth $1,177,000. Saudi Central Bank lifted its position in shares of Cardinal Health by 87.8% in the 2nd quarter. Saudi Central Bank now owns 16,472 shares of the company’s stock worth $3,913,000 after purchasing an additional 7,702 shares during the period. Finally, Nilsine Partners LLC boosted its position in Cardinal Health by 437.7% during the 2nd quarter. Nilsine Partners LLC now owns 6,049 shares of the company’s stock valued at $1,437,000 after acquiring an additional 4,924 shares in the last quarter. Institutional investors and hedge funds own 87.17% of the company’s stock.
Analyst Upgrades and Downgrades
A number of analysts have recently commented on the stock. Weiss Ratings raised shares of Cardinal Health from a “buy (b+)” rating to a “buy (a-)” rating in a research report on Monday, November 9th. Evercore reissued an “outperform” rating and issued a $270.00 target price on shares of Cardinal Health in a report on Wednesday, August 12th. Citigroup boosted their price objective on shares of Cardinal Health from $265.00 to $280.00 and gave the company a “buy” rating in a report on Wednesday, August 12th. Royal Bank Of Canada increased their target price on Cardinal Health from $276.00 to $295.00 and gave the company an “outperform” rating in a report on Friday, November 6th. Finally, Wells Fargo & Company increased their price target on shares of Cardinal Health from $277.00 to $321.00 and gave the stock an “overweight” rating in a research report on Tuesday. One research analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and two have issued a Hold rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $290.13.
Check Out Our Latest Research Report on CAH
Cardinal Health Stock Performance
Shares of NYSE:CAH opened at $272.67 on Friday. The firm has a fifty day moving average price of $247.94 and a 200 day moving average price of $226.81. Cardinal Health, Inc. has a fifty-two week low of $180.45 and a fifty-two week high of $286.29. The firm has a market cap of $63.03 billion, a price-to-earnings ratio of 35.27, a P/E/G ratio of 2.17 and a beta of 0.53.
Cardinal Health (NYSE:CAH – Get Free Report) last issued its earnings results on Thursday, November 5th. The company reported $3.26 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.94 by $0.32. The firm had revenue of $67.51 billion for the quarter, compared to analysts’ expectations of $66.67 billion. Cardinal Health had a negative return on equity of 102.72% and a net margin of 0.71%. The business’s revenue was up 5.5% compared to the same quarter last year. During the same period in the previous year, the firm posted $2.55 earnings per share. As a group, research analysts predict that Cardinal Health, Inc. will post 12.96 earnings per share for the current year.
Cardinal Health Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Friday, January 15th. Stockholders of record on Monday, January 4th will be issued a $0.5158 dividend. The ex-dividend date is Monday, January 4th. This represents a $2.06 dividend on an annualized basis and a dividend yield of 0.8%. Cardinal Health’s payout ratio is 26.65%.
About Cardinal Health
Cardinal Health is a healthcare services and products company that distributes pharmaceuticals and medical supplies. Its customers include pharmacies, hospitals, surgery centers, physician offices and other healthcare providers. The company’s businesses include pharmaceutical distribution and specialty services, as well as the sourcing and distribution of medical and surgical products. Its offerings support areas such as specialty medications, medication management and supply-chain operations. Cardinal Health traces its roots to a wholesale business founded in Ohio in 1971 and later expanded into pharmaceutical distribution.
Further Reading
- Five stocks we like better than Cardinal Health
- Survey Reveals: How Much Would People Pay for Ribeye Before Giving It Up? [2026]
- If NVIDIA Tightens Its Wallet, These 3 Stocks Could Feel It
- 3 Dividend ETFs Offering Steadier Footing in a Shaky Market
- Lazard’s New ETF Targets Monthly Income With Junk Bonds
Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.
